US FDA approves Pfizer's gene therapy for rare bleeding disorder
reut.rs/3UAkIsM
Quick Glance: FDA approves Pfizer’s gene therapy for hemophilia B
- The FDA has approved Pfizer's first gene therapy drug for a rare inherited bleeding disorder.
- Beqvez, a unique gene therapy drug by Pfizer, has been approved for adults with moderate to severe hemophilia B.
- The drug enables patients to produce Factor IX themselves to prevent and control bleeding.
- Pfizer is competing with a similar treatment from CSL Behring and planning more gene therapies for various genetic disorders.
Drugmaker AbbVie expects Humira volume erosion to worsen: AbbVie expects a drop in sales volumes of its blockbuster arthritis drug Humira to deepen after recent ...
reuters.com/business/healthcare-pharmaceuticals/abbvie-raises-annual-profit-forecast-strong-skyrizi-sales-2024-04-26/
Ex-McKinsey partner sues firm, claims he was made opioids 'scapegoat': A former McKinsey & Co partner sued the global consulting firm on Friday and accused it of ...
reuters.com/business/healthcare-pharmaceuticals/ex-mckinsey-partner-sues-firm-claims-he-was-made-opioids-scapegoat-2024-04-26/
Quick Glance: Investigation against McKinsey in the US over involvement in the opioid industry
- A grand jury was established to examine evidence related to consulting for pharmaceutical companies involved in the addiction epidemic.
- McKinsey is under a criminal investigation in the US for its involvement with opioid manufacturers.
- Furthermore, federal prosecutors are looking into whether the company impeded justice through its actions as concerns about its work grew.
- According to a source, the US Department of Justice has been scrutinizing McKinsey's activities for several years, with a grand jury now set up in Virginia to review evidence.
Chanel CEO Says Price Hikes Driven by Inflation, Craftsmanship: Chanel’s chief executive officer defended the luxury brand’s pricing after it raised the cost of ...
bloomberg.com/news/articles/2024-04-25/chanel-ceo-says-price-hikes-driven-by-inflation-craftsmanship
Paid articlePaid
Merck raises 2024 profit forecast on surging sales of cancer drug Keytruda: Merck & Co on Thursday raised its annual profit and revenue forecasts on the back of ...
reuters.com/business/healthcare-pharmaceuticals/merck-raises-2024-profit-forecast-strong-cancer-hpv-drugs-sales-2024-04-25/
Quick Glance: Merck boosts 2024 profit outlook due to Keytruda sales
- Merck & Co. raises annual profit and revenue forecasts based on double-digit growth for the blockbuster cancer drug Keytruda.
- Sales for 2024 are estimated to be between $63.1 billion and $64.3 billion, an increase from the previous forecast.
- Keytruda recorded $6.95 billion in sales in the first quarter, a 20% increase from the previous year.
- Merck also saw strong growth with its vaccine Gardasil, the drug Vaxneuvance, and a successful acquisition of Harpoon Therapeutics in the first quarter of 2024.
Scholz Gets Another Pharma Boost With New Merck KGaA Site: Merck KGaA became the latest pharma company to begin construction of a new center in Germany ...
bloomberg.com/news/articles/2024-04-25/scholz-gets-another-pharma-boost-with-new-merck-kgaa-site
Sanders launches Senate investigation into ‘outrageously high’ pricing of Ozempic, Wegovy
cnn.com/2024/04/24/health/senate-ozempic-wegovy-price/
Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth: Regeneron Pharmaceuticals and Mammoth Biosciences will collaborate to research ...
reuters.com/business/healthcare-pharmaceuticals/regeneron-collaborate-gene-editing-therapies-with-doudna-founded-mammoth-2024-04-25/
Saint Laurent Sets 3 Cannes Film Premieres With Selena Gomez, Zoe Saldaña and More
thewrap.com/wrapstyle-saint-laurent-cannes-film-premieres/
AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study
reuters.com/business/healthcare-pharmaceuticals/abbvies-skin-disease-drug-found-be-more-effective-than-regenerons-dupixent-study-2024-04-25/
AstraZeneca leaps after smashing first-quarter forecasts: AstraZeneca sailed past market expectations for quarterly revenue and profit on Thursday ...
reuters.com/business/healthcare-pharmaceuticals/astrazeneca-beats-first-quarter-revenue-profit-estimates-2024-04-25/
Bayer investor Deka takes a stand against CEO in annual vote: Bayer shareholder Deka Investment said on Friday it would not join other large investors in ...
reuters.com/business/healthcare-pharmaceuticals/bayer-investor-deka-takes-stand-against-ceo-annual-vote-2024-04-26/
Quick Glance: Successful Vote of Confidence for Bayer CEO
- Bayer CEO Bill Anderson emerges victorious in a vote of confidence at his first annual general meeting despite a challenge from Deka Investment.
- Investors representing 91.69% of equity capital voted in favor of Anderson and his top management team.
- The voting process at German annual general meetings is symbolic and serves as a reflection of investor sentiment.
- Anderson defends the decision to suspend the company's breakup and pledges to focus on drug development and legal matters.
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology: GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday ...
reuters.com/business/healthcare-pharmaceuticals/glaxosmithkline-sues-pfizer-biontech-over-covid-19-vaccine-technology-2024-04-25/
Bankruptcy allowed Mallinckrodt to end Acthar royalties, 3rd Circ. rules: Mallinckrodt's bankruptcy permitted the drug company to end a perpetual royalty ...
reuters.com/legal/litigation/bankruptcy-allowed-mallinckrodt-end-acthar-royalties-3rd-circ-rules-2024-04-25/
Gilead posts quarterly loss on acquisition charge, revenue rises 5%: Gilead Sciences reported a first-quarter loss on Thursday after taking a $3 ...
reuters.com/business/healthcare-pharmaceuticals/gilead-posts-quarterly-loss-revenue-rises-5-2024-04-25/
Bristol Myers Squibb drafts contingency plans for US restrictions on Chinese pharma
ft.com/content/f3b5f2e5-1abc-4848-8ff2-66891d5f5984
Pfizer vs Moderna battle over COVID vaccine patents begins in UK: Pfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key ...
reuters.com/business/healthcare-pharmaceuticals/pfizer-vs-moderna-battle-over-covid-vaccine-patents-begins-uk-2024-04-23/
Sanofi profit slips on generic competition and currency effects: Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to ...
reuters.com/business/healthcare-pharmaceuticals/sanofi-q1-profit-slips-generic-competition-forex-effects-2024-04-25/
Quick Glance: Sanofi Struggles with Profit Decline due to Competition and Currency Effects
- In the first quarter, Sanofi's operating income decreased by 14.7%, primarily due to currency effects and competitive pressures on their multiple sclerosis drug Aubagio, despite the increase in sales of the anti-inflammatory drug Dupixent.
- The company emphasized the forecast that adjusted earnings per share (EPS) for 2024 are expected to decrease by a low single-digit percentage, excluding currency fluctuations.
- During a media briefing, Finance chief Francois-Xavier Roger highlighted the impact of the decline in the Argentine Peso on first-quarter international sales.
- Since unexpectedly abandoning the 2025 margin targets last October under a plan to boost spending on drug development, CEO Paul Hudson has been working to restore investor confidence in the company's drug pipeline.
Sanofi (SAN FP) Asks Banks to Pitch Roles for $20 Billion OTC Spinoff: French drugmaker Sanofi has asked banks to pitch for roles on the separation of its ...
bloomberg.com/news/articles/2024-04-23/sanofi-is-said-to-ask-banks-to-pitch-for-20-billion-otc-spinoff
Alzheimer's drug adoption in US slowed by doctors' skepticism: Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer's ...
reut.rs/3Wbq0wc
Plaintiffs' lawyers chosen to lead Ozempic litigation: A federal judge has appointed eight plaintiffs' lawyers to leadership roles in federal mass tort ...
reuters.com/legal/litigation/plaintiffs-lawyers-chosen-lead-ozempic-litigation-2024-04-24/
How Novartis Rode Two Blockbusters To A Three-Day Sprint: Novartis stock jumped Tuesday after the drugmaker topped first-quarter sales and earnings forecasts ...
investors.com/news/technology/novartis-stock-novartis-earnings-q1-2024/
Quick Glance: Positive Quarterly Results Lead to Guidance Increase at Novartis
- Novartis raises its annual guidance following a successful first quarter.
- Revenue increased by 10% to $11.83 billion, with adjusted operating income growing by 16% to $4.54 billion.
- CEO Vas Narasimhan is focusing more on drug development and has been active in mergers and acquisitions.
- Novartis has secured promising drugs, including an experimental prostate cancer drug from Arvinas and the company MorphoSys, which develops cancer treatments, for 2.7 billion euros.
BASF CEO bids farewell with drop in Q1 earnings: Germany's BASF posted a drop in first-quarter adjusted earnings and sales on Thursday ...
reuters.com/business/basf-post-slight-q1-earnings-drop-beats-forecast-2024-04-25/
Alzheimer's drug adoption in US slowed by doctors' skepticism: Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer's ...
reuters.com/business/healthcare-pharmaceuticals/alzheimers-drug-adoption-us-slowed-by-doctors-skepticism-2024-04-23/
Quick Glance: Alzheimer's Drug Uptake Hindered by Doctors' Skepticism in US
- The first drug to slow the progression of Alzheimer's, Leqembi by Eisai and Biogen, is facing resistance in the US from doctors who believe the treatment is futile.
- The requirements of Leqembi, such as additional diagnostic tests, twice-monthly infusions, and regular brain scans, have led to slow adoption as many doctors express concerns about efficacy, cost, and risks.
- Despite FDA approval and proven benefits in clinical trials, many doctors still have reservations about Leqembi, hindering the widespread use of the drug.
- The companies behind Leqembi are working to improve physician and patient education to increase acceptance of the medication, aiming to treat 100,000 patients by 2026.
Haleon names Dawn Allen as CFO: Consumer healthcare firm Haleon said on Wednesday that Dawn Allen has been appointed as its new chief financial officer ...
reuters.com/business/healthcare-pharmaceuticals/haleon-names-dawn-allen-cfo-2024-04-24/
Wet food in the product test: cat food from the discounter is the price-performance winner
n-tv.de/ratgeber/Katzenfutter-vom-Discounter-ist-Preis-Leistungs-Sieger-article24901606.html
Quick Glance: Warentest: Discount Cat Food Tops the List
- The number of cats in Germany has almost doubled, emphasizing the importance of quality food.
- Warentest examined 23 wet cat foods, focusing on nutritional content and adequacy.
- Out of the products tested, 16 received good ratings, while three performed poorly.
- The price-performance winner was Lidl's cat food, priced at only 0.37 euros per day.
Cigna to offer Humira rivals with $0 copay at specialty pharmacy: Cigna plans to make close copies of AbbVie's blockbuster arthritis drug Humira available with ...
reuters.com/business/healthcare-pharmaceuticals/cigna-offer-humira-rivals-with-0-copay-specialty-pharmacy-2024-04-25/
US CDC warns of harmful reactions to fake Botox injections: The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday alerted clinicians about risks ...
reuters.com/business/healthcare-pharmaceuticals/us-cdc-warns-harmful-reactions-fake-botox-injections-2024-04-23/
Ad group WPP trails rivals with decline in organic revenue: Britain's WPP became a clear laggard among global ad companies with a drop in organic revenue drop in ...
reuters.com/business/media-telecom/ad-group-wpp-reports-16-drop-first-quarter-organic-growth-2024-04-25/
Mitsui says no decision yet on ADNOC LNG project tie-up after Nikkei report: Japan's Mitsui & Co said on Tuesday nothing has been decided on a liquefied natural ...
reuters.com/business/energy/mitsui-says-no-decision-yet-adnoc-lng-project-tie-up-after-nikkei-report-2024-04-23/
BREAKING: FTSE 100 hits fresh record high at the open as European markets rise European markets live updates: stocks, news, PMI data and earnings
Medicare beneficiaries could be eligible for Wegovy coverage, study shows
reuters.com/business/healthcare-pharmaceuticals/about-36-mln-medicare-beneficiaries-could-be-eligible-wegovy-coverage-study-2024-04-24/
Pendragon owner to cut hundreds of jobs in used car overhaul: New owner of UK dealerships will close second hand marketplace following pandemic-era slump in ...
ft.com/content/42af2045-b7a8-4739-b569-5a22cbac3416
The art of portrait — directed by Karim Sadli, the CHANEL Spring-Summer 2024 eyewear campaign stars models Liu Wen, Loli-Bahia ... Show more
Kampagne Frühjahr-Sommer 2024 — CHANEL Brillen | CHANEL
Kampagne Frühjahr-Sommer 2024 — CHANEL Brillen | CHANEL
Pharma groups warn of supply crunch over China spying law: Factory inspectors refuse to visit country over fears they could fall foul of tightened rules
ft.com/content/1d52d75f-5b54-4c27-bdd4-65409f64c64a
Swiss pharma giant Roche's first-quarter sales edge higher as its emerges from post-Covid-19 slump
cnbc.com/2024/04/24/swiss-pharma-giant-roches-first-quarter-sales-edge-higher-as-its-emerges-from-post-covid-19-slump.html
John Lewis and Waitrose applicants can see questions beforehand: The retail group hopes giving candidates sight of questions will make process fairer.
bbc.com/news/articles/c6pyqjm1219o
America’s moves against Chinese biotech will hurt patients at home : The motives behind the BIOSECURE act are muddy
economist.com/leaders/2024/04/18/americas-moves-against-chinese-biotech-will-hurt-patients-at-home
Spot the difference: Hong Kong chef's tattered tee resembles $1,500 Balenciaga top, says netizen
asiaone.com/lifestyle/spot-difference-hong-kong-chefs-tattered-tee-resembles-1500-balenciaga-top-says-netizen
Bayer CEO is getting rid of bosses: Bayer CEO Bill Anderson may be setting the tone for a new workplace trend.
thestreet.com/employment/bayer-ceo-is-getting-rid-bosses-employees-self-manage
Justin Bieber wore two humongous pairs of Balenciaga sweatpants.Justin Bieber Wore Two Humongous Pairs of Balenciaga Sweatpants at the Same Time | GQ
McKinsey faces US criminal investigation over its opioids work: McKinsey & Co is under criminal investigation in the United States over allegations that the ...
smh.com.au/business/companies/mckinsey-faces-us-criminal-probe-over-opioids-work-sources-say-20240425-p5fmih.html
This is Anthony Rees. He was seen having sex in bushes outside a Lidl store.
The pair, who displayed little regard for bystanders ... Show more
Pair caught having sex in Lidl car park - Wales Online
Pair caught having sex in Lidl car park - Wales Online
Alzheimer’s drug Leqembi falls short of blockbuster status in faltering US rollout
ft.com/content/1e02c10c-f7c4-48e9-a6a4-774531b56350
Galderma CEO Says Skincare Firm Can Fix ‘Ozempic Face’ With Fillers: Galderma Group AG’s boss has an answer for people suffering from sunken faces after taking ...
bloomberg.com/news/articles/2024-04-24/we-can-fix-your-ozempic-face-says-skincare-firm
U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents: The U.S. Supreme Court on Monday declined to hear a bid by Vanda Pharmaceuticals ...
reuters.com/legal/us-supreme-court-rejects-vanda-pharmaceuticals-case-over-sleep-drug-patents-2024-04-22/
This retailer makes as much sales as Coop, has as many branches as Migros and wants to be as cheap as Aldi and Lidl: Jumbo is the number two retailer in the ... Show more
No more meat advertising at Dutch retailer | Observer
No more meat advertising at Dutch retailer | Observer
Ozempic and Wegovy, the diabetes and weight-loss drugs, have soared to celebrity status in the U.S. But Novo Nordisk, the Danish company behind them ... Show more
Inside Novo Nordisk, the Company Behind Ozempic and Wegovy - The New York Times
Inside Novo Nordisk, the Company Behind Ozempic and Wegovy - The New York Times
Drug sales keep beating Wall Street's expectations and boosting some pharma stocks
qz.com/pharma-sales-q1-1851435519
MADEMOISELLE J12 LA PAUSA.
Discover the two watches designed by the Watch Creation Studio and donated by CHANEL to the Only Watch charity auction ... Show more
Only Watch - Chanel
Only Watch - Chanel
Hello Kitty turns 50. What will the next cat's meow be?: The global rise of Hello Kitty, who turns 50 this year, tracks that of Japanese culture. What, then ...
japantimes.co.jp/commentary/2024/04/22/japan/hello-kitty-50-years-anniversary/
Africa’s Biggest Drugmaker Aspen Can Help Ease Obesity Medicine Supply Crunch: Africa’s biggest drugmaker could potentially help ease a growing supply crunch for ...
bloomberg.com/news/articles/2024-04-22/africa-s-biggest-drugmaker-aspen-can-help-ease-obesity-medicine-supply-crunch
Costco shoppers are finding it's harder to sell gold than to buy it: Gold bars have been flying off the shelves at Costco, but some buyers are discovering that ...
businessinsider.com/costco-shoppers-finding-harder-to-sell-gold-bars-than-buy-2024-4
Despite Leon Bailey’s suspension from the Reggae Boyz and his subsequent controversial comments last month, Jamaica Football Federation (JFF) President Michael ... Show more
‘CONDITIONS APPLY’ - Jamaica Observer
‘CONDITIONS APPLY’ - Jamaica Observer
Biogen Alzheimer’s drug sales beat expectations: The Cambridge firm on Wednesday reported a first-quarter profit that exceeded estimates as it cut costs and ...
bostonglobe.com/2024/04/24/business/biogen-alzheimers-drug-leqembi/
In Case You Missed It: Regina King Wears Louis Vuitton, V. Bellan Reveals Bridal Collection, And More
essence.com/fashion/in-case-you-missed-it-regina-king-louis-vuitton-and-more/
Goldman Sachs: The Best Dividend Growth Stocks for Investors to Watch Now: Goldman Sachs recommends high-dividend stocks for 2024 with over 6% growth.
boerse-online.de/nachrichten/aktien/goldman-sachs-die-besten-dividendenwachstumsaktien-die-fuer-anleger-jetzt-interessant-sind-20355982.html
QuikTrip to close gasless store in Midtown Atlanta: The gasless QuikTrip in Midtown Atlanta will soon close.
ajc.com/news/business/quiktrip-to-close-convenience-store-in-midtown-atlanta/WMC46CDPB5EIXBTSPWXP76JD74/
Fine ounces on the rummage table: US supermarket drives customers into a gold rush - and disillusionment
n-tv.de/wirtschaft/US-Supermarkt-treibt-Kunden-in-Goldrausch-und-Ernuechterung-article24896005.html
Aldi issues urgent 'do not eat' warning as police investigate if product was 'tampered with'
itv.com/news/2024-04-23/urgent-warning-to-aldi-customers-as-police-probe-if-product-was-tampered-with
Men caught having sex in the bush of Lidl car park in Cardiff: Two men were caught having sex in the bush of a Lidl car park in Cardiff next to shoppers.
metro.co.uk/2024/04/25/men-caught-sex-bush-lidl-car-park-cardiff-20716169/
Colchester new Home Bargains store to be 'biggest' in city: The country-wide chain, which already has a site at Turner Rise Retail Park, has revealed its plans ...
gazette-news.co.uk/news/24270957.home-bargains-open-new-site-colchester-old-b-q-site/
In an interview, the outgoing CEO complained that Germany had fallen far behind in international comparison.
What is particularly frustrating for him is that ... Show more
“Makes me angry”: Business boss clearly counts German industrial policy - FOCUS online
“Makes me angry”: Business boss clearly counts German industrial policy - FOCUS online
Research: More People Use Mental Health Benefits When They Hear That Colleagues Use Them Too
hbr.org/2024/04/research-more-people-use-mental-health-benefits-when-they-hear-that-colleagues-use-them-too
Do you get confused by price tags when grocery shopping? 🛒
New research has found that promotional labels displayed by Australia's supermarket giants are ... Show more
Supermarket giants' promotional labels 'confusing and misleading'
Supermarket giants' promotional labels 'confusing and misleading'
Markus Kamieth follows Martin Brudermüller: A new era is dawning for BASF: Martin Brudermüller has brought the world's largest chemical company on course for ...
faz.net/aktuell/wirtschaft/markus-kamieth-folgt-auf-martin-brudermueller-fuer-basf-bricht-eine-neue-zeit-an-19666131.html
Paid articlePaid
Nord Stream sabotage: China calls for international investigation: Beijing on Friday called on the United Nations to open an investigation into explosions that ...
berliner-zeitung.de/news/nord-stream-sabotage-china-fordert-internationale-untersuchung-li.2209925
Paid articlePaid
Aldi, Lidl, Edeka and Co offer many own food brands that are produced by brand manufacturers. The producer is often not listed on the packaging ... Show more
Own brands from Rewe, Lidl and Co: Who is the manufacturer? | NDR.de - Guide - Consumer
Own brands from Rewe, Lidl and Co: Who is the manufacturer? | NDR.de - Guide - Consumer
It’s 4/5 for Max Verstappen in 2024, he WINS the #ChineseGP ! 👏
2. Norris +13.7s
3. Perez
4. Leclerc
5. Sainz #F1
Zach Hyman gets the first hat trick of these #StanleyCup Playoffs!!! 🎩🎩🎩
Hat Trick Challenge presented by AstraZeneca US
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics